{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:19:23Z","timestamp":1737436763889,"version":"3.33.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Srinakharinwirot University","award":["005\/2567"],"award-info":[{"award-number":["005\/2567"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-025-03821-y","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T17:43:25Z","timestamp":1737395005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the efficacy and safety profiles of 0.025% tretinoin in treating axillary hyperpigmentation with acanthosis nigricans: a randomized double-blinded study"],"prefix":"10.1007","volume":"317","author":[{"given":"Puri","family":"Chunekamrai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattasit","family":"Chatpimolkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soravit","family":"Thummawatwimon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8299-988X","authenticated-orcid":false,"given":"Arucha","family":"Treesirichod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"issue":"3","key":"3821_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/2229-5178.137765","volume":"5","author":"M Phiske","year":"2014","unstructured":"Phiske M (2014) An approach to acanthosis nigricans. Indian Dermatol Online J 5(3):239\u2013249","journal-title":"Indian Dermatol Online J"},{"issue":"8","key":"3821_CR2","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jocd.13544","volume":"19","author":"A Das","year":"2020","unstructured":"Das A, Datta D, Kassir M, Wollina U, Galadari H, Lotti T et al (2020) Acanthosis nigricans: a review. J Cosmet Dermatol 19(8):1857\u20131865","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"3821_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00403-022-02472-7","volume":"315","author":"C Kritsanaviparkporn","year":"2023","unstructured":"Kritsanaviparkporn C, Treesirichod A (2023) Comparing the efficacy and safety profiles of 0.025% and 0.05% tretinoin creams in treating acanthosis nigricans: a randomized double-blinded study. Arch Dermatolog Res 315(4):963\u2013970 2023\/05\/01","journal-title":"Arch Dermatolog Res"},{"issue":"7","key":"3821_CR4","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/09546634.2019.1708855","volume":"32","author":"A Treesirichod","year":"2020","unstructured":"Treesirichod A, Chaithirayanon S, Chaikul T, Chansakulporn S (2020) The randomized trials of 10% urea cream and 0.025% tretinoin cream in the treatment of acanthosis nigricans. J Dermatolog Treat 32(7):837\u2013842","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"3821_CR5","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00403-023-02605-6","volume":"315","author":"A Treesirichod","year":"2023","unstructured":"Treesirichod A, Thaneerat N, Kangvanskol W (2023) A comparison of the efficacy and safety profiles of 10% salicylic acid and 10% urea creams in treating acanthosis nigricans in adolescents: a randomized double-blinded study. Arch Dermatol Res 315(7):2091\u20132097","journal-title":"Arch Dermatol Res"},{"issue":"4","key":"3821_CR6","first-page":"290","volume":"7","author":"A Ehsani","year":"2016","unstructured":"Ehsani A, Noormohammadpour P, Goodarzi A, Mirshams Shahshahani M, Hejazi SP, Hosseini E et al (2016) Comparison of long-pulsed alexandrite laser and topical tretinoin-ammonium lactate in axillary acanthosis nigricans: a case series of patients in a before-after trial. Casp J Intern Med 7(4):290\u2013293","journal-title":"Casp J Intern Med"},{"key":"3821_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2147\/CCID.S401479","volume":"16","author":"MF Elmasry","year":"2023","unstructured":"Elmasry MF, Khalil MMF, Badawi A, Zaki NS, Fahim A (2023) Efficacy of Fractional Carbon Dioxide (CO(2)) laser versus Q-Switched neodymium-doped Yttrium Aluminum Garnet (nd:YAG) and potassium-titanyl-phosphate (KTP) lasers in the treatment of Acanthosis nigricans. Clin Cosmet Investig Dermatol 16:705\u2013715","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"3821_CR8","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10103-019-02944-9","volume":"35","author":"P Leerapongnan","year":"2020","unstructured":"Leerapongnan P, Jurairattanaporn N, Kanokrungsee S, Udompataikul M (2020) Comparison of the effectiveness of fractional 1550-nm erbium fiber laser and 0.05% tretinoin cream in the treatment of acanthosis nigricans: a prospective, randomized, controlled trial. Lasers Med Sci 35(5):1153\u20131158","journal-title":"Lasers Med Sci"},{"key":"3821_CR9","doi-asserted-by":"crossref","unstructured":"Bitterman D, Patel P, Zafar K, Wang J, Kabakova M, Mineroff Gollogly J et al (2024) Systematic review of topical, laser, and oral treatments in acanthosis nigricans clinical trials. Arch Dermatolog Res.;316(7)","DOI":"10.1007\/s00403-024-02931-3"},{"issue":"1","key":"3821_CR10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1573396318666220429085231","volume":"19","author":"AKC Leung","year":"2023","unstructured":"Leung AKC, Lam JM, Barankin B, Leong KF, Hon KL (2023) Acanthosis nigricans: an updated review. Curr Pediatr Rev 19(1):68\u201382","journal-title":"Curr Pediatr Rev"},{"issue":"1","key":"3821_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4274\/jcrpe.1515","volume":"7","author":"\u00d6 Pirgon","year":"2015","unstructured":"Pirgon \u00d6, Sandal G, G\u00f6k\u00e7en C, Bilgin H, D\u00fcndar B (2015) Social anxiety, Depression and Self-Esteem in obese adolescent girls with acanthosis nigricans. J Clin Res Pediatr Endocrinol 7(1):63\u201368","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"1","key":"3821_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4103\/0019-5154.147838","volume":"60","author":"A Treesirichod","year":"2015","unstructured":"Treesirichod A, Chaithirayanon S, Wongjitrat N, Wattanapan P (2015) The efficacy of topical 0.1% adapalene gel for use in the treatment of childhood acanthosis nigricans: a pilot study. Indian J Dermatol 60(1):103","journal-title":"Indian J Dermatol"},{"issue":"3","key":"3821_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/pde.13799","volume":"36","author":"A Treesirichod","year":"2019","unstructured":"Treesirichod A, Chaithirayanon S, Wongjitrat N (2019) Comparison of the efficacy and safety of 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of childhood acanthosis nigricans. Pediatr Dermatol 36(3):330\u2013334","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"3821_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/09546630802050506","volume":"19","author":"S Gregoriou","year":"2009","unstructured":"Gregoriou S, Anyfandakis V, Kontoleon P, Christofidou E, Rigopoulos D, Kontochristopoulos G (2009) Acanthosis nigricans associated with primary hypogonadism: successful treatment with topical calcipotriol. J Dermatolog Treat 19(6):373\u2013375","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"3821_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/09546634.2012.674194","volume":"25","author":"A Zayed","year":"2012","unstructured":"Zayed A, Sobhi RM, Abdel Halim DM (2012) Using trichloroacetic acid in the treatment of acanthosis nigricans: a pilot study. J Dermatolog Treat 25(3):223\u2013225","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"3821_CR16","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1111\/jocd.16224","volume":"23","author":"M Ghiasi","year":"2024","unstructured":"Ghiasi M, Samii R, Tootoonchi N, Balighi K, Heidari S (2024) Comparison of efficacy and safety of tretinoin 0.05% and glycolic acid peeling 70% in axillary and neck lesions of acanthosis nigricans: a single-blinded, randomized trial. J Cosmet Dermatol 23(6):2090\u20132096","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"3821_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0190-9622(97)80129-6","volume":"37","author":"EA Olsen","year":"1997","unstructured":"Olsen EA, Katz HI, Levine N, Nigra TP, Pochi PE, Savin RC et al (1997) Sustained improvement in photodamaged skin with reduced tretinoin emollient cream treatment regimen: Effect of once-weekly and three-times-weekly applications. J Am Acad Dermatol 37(2):227\u2013230","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3821_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1468-3083.2011.04135.x","volume":"26","author":"I Arellano","year":"2011","unstructured":"Arellano I, Cestari T, Ocampo-Candiani J, Azulay\u2010Abulafia L, Bezerra Trindade Neto P, Hexsel D et al (2011) Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long\u2010standing clinical severity. J Eur Acad Dermatol Venereol 26(5):611\u2013618","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"3821_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jtv.2020.12.005","volume":"30","author":"IHJ Everink","year":"2021","unstructured":"Everink IHJ, Kottner J, van Haastregt JCM, Halfens R, Schols JMGA (2021) Skin areas, clinical severity, duration and risk factors of intertrigo: a secondary data analysis. J Tissue Viability 30(1):102\u2013107","journal-title":"J Tissue Viability"},{"key":"3821_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2147\/CCID.S39246","volume":"6","author":"JP Castanedo-Cazares","year":"2013","unstructured":"Castanedo-Cazares JP, Larraga P, Ehnis-Perez A, Fuentes A, Oros O, Smoller et al (2013) Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study. Clin Cosmet Investig Dermatol 6:29\u201336","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"1","key":"3821_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.36849\/JDD.2020.4623","volume":"19","author":"IGC Robredo","year":"2020","unstructured":"Robredo IGC (2020) Q-Switched 1064 nm nd:YAG Laser in treating Axillary Hyperpigmentation in Filipino Women with skin types IV-V. J Drugs Dermatol 19(1):66\u201369","journal-title":"J Drugs Dermatol"},{"issue":"9","key":"3821_CR22","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1111\/jocd.13981","volume":"20","author":"W Amornpetkul","year":"2021","unstructured":"Amornpetkul W, Kanokrungsee S, Kamanamool N, Udompataikul M, Rojhirunsakool S (2021) Comparison between the use of intense pulsed light and Q-switched neodymium\u2010doped yttrium aluminum garnet laser for the treatment of axillary hyperpigmentation. J Cosmet Dermatol 20(9):2785\u20132793","journal-title":"J Cosmet Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03821-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-025-03821-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-025-03821-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T17:43:29Z","timestamp":1737395009000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-025-03821-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3821"],"URL":"https:\/\/doi.org\/10.1007\/s00403-025-03821-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Institutional Review Board and Ethics Committee of Srinakharinwirot University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients have provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent has been provided by all patients before enrolment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SWUEC 360\/2565F.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}},{"value":"NCT06213987.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trials registry"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}